Evidence-first health & aging science Newsletter
Live Well News Live Well News
Back to Nutrition & Diet

News · Nutrition & Diet

Saturated fat tracked 24% more deaths after prostate cancer, but not from the cancer

Most men diagnosed with early prostate cancer do not die of it. Following 4,884 of them for over a decade, what they ate afterwards moved every cause of death except the one they were treated for.

A block of butter and a wooden knife on a ceramic plate
Summary
  • Men eating the most saturated fat after diagnosis died sooner from all causes.
  • Heart disease deaths rose the most, by about 42%.
  • Prostate cancer death itself showed no link to any dietary fat.
  • Swapping animal fat for plant fat tracked 16% fewer deaths.
  • 4,884 US men followed a median of nearly 13 years.

A man diagnosed with early prostate cancer is usually told, correctly, that the odds are good. The disease is often slow, treatment works, and the great majority of men with cancer confined to the prostate are alive many years later.

What that framing skips is the question of what they do die of. Prostate cancer is one of the most common types of cancer and it is also one of the most survivable, which means the men in question spend decades living with everything else that kills people their age.

Writing in JAMA Network Open, researchers followed 4884 patients with nonmetastatic prostate cancer and asked what their diet after diagnosis did to that longer story. Previously the evidence on eating after a prostate cancer diagnosis had been thin enough that no clear survivorship advice existed.

The finding, and the absence at the center of it

Men in the top fifth for saturated fat intake after diagnosis had around 24% higher risk of dying from any cause than men in the bottom fifth. Cardiovascular deaths were around 42% higher.

Then the part that gives the study its shape: there were no associations between dietary fats and prostate cancer mortality. None of the fats moved deaths from the disease the men were being treated for.

Over a median follow-up of nearly thirteen years, 3040 deaths from any cause were recorded. Most of them were not prostate cancer.

Why the null is the point

A dietary study that found nothing for the headline outcome would normally be a disappointing result. Here it is the informative one.

It says the fat is not acting on the tumor. Whatever saturated fat is doing, it is doing it through the ordinary channels by which diet affects a body over a decade, mostly the arteries, and those channels are open regardless of whether someone has had a cancer diagnosis.

That reframes what survivorship advice should be about. A man five years past treatment for localized prostate cancer is, statistically, far more likely to be killed by his heart than by his prostate, and the diet advice that matters follows from that rather than from the cancer.

The heart connection is not incidental

Prostate cancer treatment has its own cardiovascular cost. Androgen deprivation therapy, used widely, is associated with weight gain, insulin resistance and adverse changes in blood lipids, all pushing in the same direction.

So the population under study is one whose cardiovascular risk has often been raised by their treatment, eating a diet that raises it further. The 42% figure lands on a group already tilted that way.

The substitution question

The more useful analysis is not whether saturated fat is harmful in isolation but what happens when something replaces it, because calories displaced have to go somewhere.

Replacing 10% of calories from animal fats with plant-based fats was associated with about 16% lower all-cause mortality. Exchanging 5% of calories from saturated fats for monounsaturated fats gave a similar direction, around 20% lower.

Those are modeled exchanges rather than observed interventions, which is a real limitation. They are also the form in which dietary advice is actually given, since nobody eats less of something without eating more of something else.

What a cohort of health professionals can and cannot show

The Health Professionals Follow-Up Study has run since 1986 with diet measured every four years by questionnaire. Repeated measurement over decades is a genuine strength; most dietary studies capture eating once and assume it holds.

The weaknesses are the familiar ones. Food frequency questionnaires are imprecise instruments, and people under-report the things they feel judged about, which here means under-reporting exactly the foods being studied.

Reverse causation deserves naming too. Men whose health is already declining eat differently, and a diagnosis of any kind changes what a person puts on their plate. Diet measured after diagnosis sits in the middle of that.

The cohort is also male health professionals, which is a group with more education, more income and better healthcare access than the average man with prostate cancer.

Where it leaves things

Not with a rule about fat. This is one observational cohort, and the debate about saturated fat has consumed far larger bodies of evidence without resolving.

What it does supply is a corrective to how survivorship gets discussed. The question after an early prostate cancer diagnosis is often narrowed to the cancer, its monitoring and its recurrence, when the arithmetic of what actually kills these men points somewhere else entirely.

On the evidence here, the diet conversation after a prostate cancer diagnosis is a cardiology conversation.

People also ask

What did the study find?

Comparing the highest with the lowest quintile of postdiagnostic saturated fat intake, all-cause mortality was higher (HR 1.24; 95% CI 1.05-1.47) as was cardiovascular mortality (HR 1.42; 95% CI 1.02-1.98). Replacing 10% of calories from animal fats with plant-based fats was associated with lower all-cause mortality (HR 0.84; 95% CI 0.76-0.93). There were no associations between dietary fats and prostate cancer mortality.

Why does prostate cancer mortality show nothing?

Because most men with nonmetastatic disease do not die of it. Over a median 12.8 years, deaths in this group came mostly from heart disease and other cancers, which is where a dietary signal has room to appear.

Is this about the cancer at all then?

Indirectly. It is about survivorship: what actually kills men after an early prostate cancer diagnosis, and whether diet moves those causes. Treatment for prostate cancer can itself raise cardiovascular risk, which makes the heart finding more relevant, not less.

What does the substitution analysis add?

It answers a more useful question than 'is saturated fat bad'. Calories have to come from somewhere, so modeling the exchange shows what happens when plant fats replace animal fats rather than treating intake as if it floated free.

How reliable is measuring diet this way?

Food frequency questionnaires every four years are the standard tool for cohorts this size and they are imprecise. Repeating them over decades helps, and it does not eliminate misreporting, which tends to run in the direction of under-reporting less healthy foods.

Could sicker men simply eat differently?

That is the main alternative. Men who are already unwell change what they eat, and men who eat more plant fat differ in exercise, weight and smoking. The analysis adjusts for recorded factors, and this is an observational cohort rather than a trial.

What is the practical reading?

That advice after a prostate cancer diagnosis probably has more to do with the heart than with the prostate. Any dietary change belongs in a conversation with the treating team. This is general information rather than medical advice.

References

  1. Dietary Fat Intake and Mortality Among Patients With Nonmetastatic Prostate Cancer. JAMA Network Open, 2026.
  2. MedlinePlus. Prostate Cancer. US National Library of Medicine.
Search